Northwest Biotherapeutics | NWBO - DEBITO





DEBITO Cambiamento Data
Agenus USD 35.54M 2.34M 2025-03
AstraZeneca USD 32.24B 1.68B 2026-06
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Celldex Therapeutics USD 1.91M 428K 2026-03
Eisai JPY 186.08B 50.58B 2026-03
Merck USD 49.12B 222M 2026-03
Northwest Biotherapeutics USD 32.94M 6.93M 2023-09
Pfizer USD 63.19B 536M 2026-06
Plus Therapeutics USD 3.98M 372K 2023-12
Roche Holding CHF 33.03B 1.41B 2025-06